Non-hallucinogenic weight loss therapy also targets fatty liver
MEAI-PEA combo enters international PCT patent for obesity and MASLD; obesity affects over 890M adults, MASLD about 30% of the global adult population.
www.stocktitan.netI don’t have live access to the latest news right now. Here’s what’s publicly available about Neuro Labs up to early 2026, with caveats on scope and recency.
-
Neuro Event Labs has seen notable funding activity in recent years, including a €2.0M round to support European and US market expansion for its AI-powered seizure-detection device Nelli, signaling investor interest in AI-enabled neurology diagnostics. This reflects broader investor attention to neurodiagnostics startups and at-home monitoring solutions.[2][4]
-
Regulatory progress continues to shape the space, with several neuro-focused devices receiving FDA or European regulatory clearances or certifications for neuromodulation and seizure monitoring, underscoring an active regulatory environment for neuro-tech products.[1][8][9][2]
-
The broader ecosystem includes activity around brain-computer interfaces, neuromodulation therapies, and brain network mapping, with multiple companies announcing funding rounds, collaborations, or product approvals in late 2025 and early 2026, indicating sustained momentum in neurotech investment and commercialization.[1][2]
How I can help next
- If you want, I can narrow to a specific "Neuro Labs" entity (there are several neurotech firms with similar names) or track a particular product (e.g., seizure detection, neuromodulation, iBCI). I can then search for the most recent press releases, regulatory filings, and funding rounds and summarize with citations.
- I can also compile a brief timeline or a quick status table (funding, approvals, partnerships) for the exact entity you mean.
If you confirm the exact organization (full legal name or a link you have in mind), I’ll pull the latest verified updates and provide a concise, cited briefing.